Home > Qtrly Results > GLAND PHARMA

GLAND PHARMA
Quarterly Results Analysis [Jun2025]

GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Quarterly Results

Consolidated Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Revenues ₹1,506 Cr ₹1,425 Cr ₹1,384 Cr ₹1,406 Cr ₹1,402 Cr ₹1,537 Cr ₹1,545 Cr ₹1,373 Cr
Expenses ₹1,138 Cr ₹1,077 Cr ₹1,024 Cr ₹1,109 Cr ₹1,137 Cr ₹1,179 Cr ₹1,189 Cr ₹1,049 Cr
Operating Income ₹368 Cr ₹348 Cr ₹360 Cr ₹297 Cr ₹264 Cr ₹359 Cr ₹356 Cr ₹324 Cr
Other Income ₹58 Cr ₹44 Cr ₹58 Cr ₹60 Cr ₹51 Cr ₹42 Cr ₹37 Cr ₹53 Cr
Interest ₹11 Cr ₹7 Cr ₹23 Cr ₹6 Cr ₹6 Cr ₹10 Cr ₹5 Cr ₹6 Cr
Depreciation ₹101 Cr ₹96 Cr ₹96 Cr ₹94 Cr ₹92 Cr ₹93 Cr ₹105 Cr ₹81 Cr
Profit Before Tax ₹313 Cr ₹288 Cr ₹299 Cr ₹257 Cr ₹218 Cr ₹298 Cr ₹283 Cr ₹290 Cr
Profit After Tax ₹215 Cr ₹187 Cr ₹205 Cr ₹164 Cr ₹144 Cr ₹192 Cr ₹192 Cr ₹194 Cr
EPS ₹13.08 ₹11.32 ₹12.42 ₹9.93 ₹8.73 ₹11.68 ₹11.65 ₹11.78
Industry Peers & Returns1W1M1Y
GLAND PHARMA 0.2% -4.4% 0.3%
SUN PHARMACEUTICAL INDUSTRIES 1% -0.9% -13%
DIVIS LABORATORIES -1.6% -1.8% 17.9%
CIPLA -1.8% 3.7% -6%
TORRENT PHARMACEUTICALS 0.7% 2.4% 3.4%
DR REDDYS LABORATORIES -0.6% 4.5% -6.5%
MANKIND PHARMA 1.4% 1% 5.8%
ZYDUS LIFESCIENCES 1.3% 8.2% -10.1%
LUPIN 3.1% 5.2% -14.6%

GLAND PHARMA Quarterly Revenues

Revenues
Q-o-Q

5.66 %

Y-o-Y

7.41 %

Quarters Revenues % Change
Jun2025 ₹1,506 Cr
5.66
Mar2025 ₹1,425 Cr
2.95
Dec2024 ₹1,384 Cr
-1.55
Sep2024 ₹1,406 Cr
0.29
Jun2024 ₹1,402 Cr
-8.83
Mar2024 ₹1,537 Cr
-0.50
Dec2023 ₹1,545 Cr
12.50
Sep2023 ₹1,373 Cr -

GLAND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

5.83 %

Y-o-Y

39.09 %

Quarters Operating Profit % Change
Jun2025 ₹368 Cr
5.83
Mar2025 ₹348 Cr
-3.46
Dec2024 ₹360 Cr
21.17
Sep2024 ₹297 Cr
12.35
Jun2024 ₹264 Cr
-26.28
Mar2024 ₹359 Cr
0.63
Dec2023 ₹356 Cr
9.97
Sep2023 ₹324 Cr -
Operating Margins
Q-o-Q

0.16 %

Y-o-Y

29.53 %

Quarters Operating Margin% % Change
Jun2025 24.43%
0.16
Mar2025 24.39%
-6.23
Dec2024 26.01%
23.10
Sep2024 21.13%
12.04
Jun2024 18.86%
-19.16
Mar2024 23.33%
1.17
Dec2023 23.06%
-2.29
Sep2023 23.6% -

GLAND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

15.51 %

Y-o-Y

49.89 %

Quarters Profit After Tax % Change
Jun2025 ₹215 Cr
15.51
Mar2025 ₹187 Cr
-8.87
Dec2024 ₹205 Cr
25.17
Sep2024 ₹164 Cr
13.75
Jun2024 ₹144 Cr
-25.29
Mar2024 ₹192 Cr
0.29
Dec2023 ₹192 Cr
-1.15
Sep2023 ₹194 Cr -
PAT Margins
Q-o-Q

9.32 %

Y-o-Y

39.47 %

Quarters PAT Margin(%) % Change
Jun2025 14.31 %
9.32
Mar2025 13.09 %
-11.49
Dec2024 14.79 %
27.17
Sep2024 11.63 %
13.35
Jun2024 10.26 %
-18.05
Mar2024 12.52 %
0.81
Dec2023 12.42 %
-12.10
Sep2023 14.13 % -

GLAND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

15.55 %

Y-o-Y

49.83 %

Quarters EPS % Change
Jun2025 ₹13.08
15.55
Mar2025 ₹11.32
-8.86
Dec2024 ₹12.42
25.08
Sep2024 ₹9.93
13.75
Jun2024 ₹8.73
-25.26
Mar2024 ₹11.68
0.26
Dec2023 ₹11.65
-1.10
Sep2023 ₹11.78 -

You may also like the below Video Courses